Obesity Research Study
The purpose of this study is to evaluate the effectiveness and safety of giving canagliflozin together with phentermine compared with placebo in the treatment of non-diabetic overweight subjects.
This study will last for approximately 28 weeks with a total of 7 office visits and 3 phone calls. You will be compensated for time and travel. You may qualify if the following apply to you:
Think you might qualify? Got questions about the study? Great! Fill out our Volunteer Interest Form or give us a call for more information on this research study.
|